Florida-California Cancer Research Education & Engagement (CaRE2) Health Equity Center​​
​​
FAMU RESEARCH EDUCATION CORE (REC). Core Leader: Bereket Mochona, Ph.D.​
Funding period 1 2018 - 2023 (completed)
​ Funding period 2 2023 - 2028 (Active)
​​
​
​
​
​​​​
Intramural funding:
Pilot project (PI) 05/2016 – 07/2017 $25,000
“Mutual Interplay between Anti-apoptotic BCl-2 Family Protein Inhibitors and Androgen Receptor Antagonists.”(PI).
​
Pilot project (PI). 04/2015 – 05/2016 $20,000
“Synthesis and Anticancer Activities of Some Pyrrolyl-1,3,4-Oxidazole and Pyrrolyl-4-Aminoantipyrines.”(PI)
Pilot project (PI) 11/2013 – 11/2014 $10,000
“Oxadiazolopyrroles, Oxadiazolobenzimidazoles Synthesis and Preliminary Biological Evaluations as Anticancer Agents.”(PI)
​
FAMU Graduate Studies (FRAP) 8/1/2013 – 12/2014 $4,000
2-Pyrolylbenzimidazoles: Synthesis and Preliminary Biological Evaluations as Nonsteroidal Prostate Cancer Agents. (PI)
FAMU-RCMI 11/2012 – 11/2013 $7,500
“Synthesis of Benzimidazole Analogs as Anti-allergic Agents.” (PI)
​
Pilot project (PI). 11/2007 – 11/2008 $7,000
“Synthesis of Benzimidazole Analogs as Anti-allergic Agents.” (PI)
Pilot project (PI) 11/2013 – 11/2014 $10,000
“Synthesis of Benzimidazole Analogs as Anti-allergic Agents.”
Travel Award
-
International Travel Award to establish research collaboration: Bielefeld University of Applied Sciences, Germany 2024 $3,543.59
-
Florida Health Equity Research Institute Scholar Travel Award 2020 $1000.00
-
FAMU-Academic Affairs Travel Award 2016 $3,500.00
-
RCMI Junior Faculty Professional Development Travel Award 2010 $3,000.00
-
RCMI Junior Faculty Professional Development Travel Award 2010 $3000.00